Author + information
The authors have noted an error in Table 2and Figure 1. The major implication is that reduction of nonfatal stroke associated with CCB use for hypertension does not outweigh but almost exactly balances the increase in MI. Corrected data show a relative risk for nonfatal stroke of 0.842 (p = 0.013). The relative risk for nonfatal MI remains 1.17 (p = 0.036). Respective Bonferroni-corrected p values for nonfatal stroke and nonfatal MI are 0.052 and 0.144. In addition, in type 2 diabetics, CCBs increased major cardiovascular events with relative risk not of 1.258 but of 1.339 (confidence intervals 1.074 to 1.670, p = 0.010), thereby more strongly supporting the provisional hypothesis that CCBs may be less safe than ACE inhibitors in diabetics. The revised Table 2and Figure 1are printed here. The authors apologize for the error.
- American College of Cardiology Foundation